Ahmedabad-headquartered life sciences firm Cliantha Research has acquired contract research firm Karmic Lifesciences for an undisclosed amount.
Commenting on the development, Cliantha Research Executive Director Vijay Patel said: "Karmic gives us an opportunity to expand in the clinical data management, pharmaceutical analytics and medical marketing business."
Cliantha Research shall immediately be able to execute and port all its trials on to kTrials eClinical Suite, he added.
"Cliantha brings in strong clinical, bio-analytical and diagnostics capabilities that lend huge synergy to our existing clinical business, apart from the strategic flexibility and financial stability of a well-established partner," Karmic Lifesciences CEO Nidhi Saxena said.
Karmic Lifesciences has executed 150-plus clinical trials and 75-plus clinical data management & bio-statistics projects (Phase I to IV) in various therapeutic areas such as oncology, cardiovascular, diabetes, neurology, auto-immune diseases, ophthalmology and medical devices, Cliantha Research said in a statement.
